Sign In

Login

Password

Forgot Password ? Sign Up

Primárna sklerotizujúca cholangitída (Slovak Wikipedia)

Analysis of information sources in references of the Wikipedia article "Primárna sklerotizujúca cholangitída" in Slovak language version.

refsWebsite
Global rank Slovak rank
23doi.org
2nd place
7th place
23worldcat.org
5th place
1st place

doi.org

dx.doi.org

  • LAZARIDIS, Konstantinos N.; LARUSSO, Nicholas F.. Primary Sclerosing Cholangitis. New England Journal of Medicine, 2016-09-22, roč. 375, čís. 12, s. 1161–1170. Dostupné online [cit. 2019-02-05]. ISSN 0028-4793. DOI: 10.1056/nejmra1506330.
  • FOLSERAAS, Trine; BOBERG, Kirsten Muri. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease, 2016-02, roč. 20, čís. 1, s. 79–98. Dostupné online [cit. 2019-02-05]. ISSN 1089-3261. DOI: 10.1016/j.cld.2015.08.014.
  • KUMMEN, Martin; SCHRUMPF, Erik; BOBERG, Kirsten Muri. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology, 2013-08, roč. 27, čís. 4, s. 531–542. Dostupné online [cit. 2019-02-05]. ISSN 1521-6918. DOI: 10.1016/j.bpg.2013.06.013.
  • CHARATCHAROENWITTHAYA, Phunchai; LINDOR, Keith D.. Primary sclerosing cholangitis: Diagnosis and management. Current Gastroenterology Reports, 2006-02, roč. 8, čís. 1, s. 75–82. Dostupné online [cit. 2019-02-05]. ISSN 1522-8037. DOI: 10.1007/s11894-006-0067-8.
  • SCHAFFNER, Fenton. Gastrointestinal disease: Pathophysiology diagnosis management. 4th ed. Edited by Marvin H. Sleisenger and John S. Fordtran, 2,027 pp. Philadelphia: W. B. Saunders Co., 1989. $155. Hepatology, 1990-10, roč. 12, čís. 4, s. 788–789. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.1840120431.
  • WILLIAMSON, Kate D.; CHAPMAN, Roger W.. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin, 2015-05-16, roč. 114, čís. 1, s. 53–64. Dostupné online [cit. 2019-02-05]. ISSN 0007-1420. DOI: 10.1093/bmb/ldv019.
  • TABIBIAN, James H.; YANG, Ju Dong; BARON, Todd H.. Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. Digestive Diseases and Sciences, 2015-09-21, roč. 61, čís. 1, s. 53–61. Dostupné online [cit. 2019-02-05]. ISSN 0163-2116. DOI: 10.1007/s10620-015-3853-z.
  • TABIBIAN, James H.; ABU DAYYEH, Barham K.; GORES, Gregory J.. A novel, minimally invasive technique for management of peristomal varices. Hepatology, 2015-07-04, roč. 63, čís. 4, s. 1398–1400. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.27925.
  • TABIBIAN, James H; LINDOR, Keith D. Primary sclerosing cholangitis: a review and update on therapeutic developments. Expert Review of Gastroenterology & Hepatology, 2013-02, roč. 7, čís. 2, s. 103–114. Dostupné online [cit. 2019-02-05]. ISSN 1747-4124. DOI: 10.1586/egh.12.80.
  • O’HARA, Steven P.; TABIBIAN, James H.; SPLINTER, Patrick L.. The dynamic biliary epithelia: Molecules, pathways, and disease. Journal of Hepatology, 2013-03, roč. 58, čís. 3, s. 575–582. Dostupné online [cit. 2019-02-05]. ISSN 0168-8278. DOI: 10.1016/j.jhep.2012.10.011.
  • TABIBIAN, James H.; O’HARA, Steven P.; LINDOR, Keith D.. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scandinavian Journal of Gastroenterology, 2014-07-03, roč. 49, čís. 8, s. 901–908. Dostupné online [cit. 2019-02-05]. ISSN 0036-5521. DOI: 10.3109/00365521.2014.913189.
  • TABIBIAN, James H.; VARGHESE, Cyril; O'HARA, Steven P.. Microbiome-immune interactions and liver disease. Clinical Liver Disease, 2015-04, roč. 5, čís. 4, s. 83–85. Dostupné online [cit. 2019-02-05]. ISSN 2046-2484. DOI: 10.1002/cld.453.
  • TABIBIAN, James H.; VARGHESE, Cyril; LARUSSO, Nicholas F.. The enteric microbiome in hepatobiliary health and disease. Liver International, 2015-12-12, roč. 36, čís. 4, s. 480–487. Dostupné online [cit. 2019-02-05]. ISSN 1478-3223. DOI: 10.1111/liv.13009.
  • TABIBIAN, James H.; O'HARA, Steven P.; SPLINTER, Patrick L.. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology, 2014-04-25, roč. 59, čís. 6, s. 2263–2275. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.26993.
  • TABIBIAN, James H; TRUSSONI, Christy E; O'HARA, Steven P. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis. Laboratory Investigation, 2014-07-21, roč. 94, čís. 10, s. 1126–1133. Dostupné online [cit. 2019-02-05]. ISSN 0023-6837. DOI: 10.1038/labinvest.2014.94.
  • HIRSCHFIELD, Gideon M; KARLSEN, Tom H; LINDOR, Keith D. Primary sclerosing cholangitis. The Lancet, 2013-11, roč. 382, čís. 9904, s. 1587–1599. Dostupné online [cit. 2019-02-05]. ISSN 0140-6736. DOI: 10.1016/s0140-6736(13)60096-3.
  • TABIBIAN, James H; MACURA, Slobodan I; O'HARA, Steven P. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography. Laboratory Investigation, 2013-04-15, roč. 93, čís. 6, s. 733–743. Dostupné online [cit. 2019-02-05]. ISSN 0023-6837. DOI: 10.1038/labinvest.2013.52.
  • TABIBIAN, James H.; LINDOR, Keith D.. Primary Sclerosing Cholangitis. Cham : Springer International Publishing, 2016-11-13. Dostupné online. ISBN 9783319409061. S. 145–152.
  • LINDOR, Keith D.; KOWDLEY, Kris V.; LUKETIC, Velimir A. C.. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 2009-05-20, roč. 50, čís. 3, s. 808–814. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.23082.
  • EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology, 2009-08, roč. 51, čís. 2, s. 237–267. Dostupné online [cit. 2019-02-05]. ISSN 0168-8278. DOI: 10.1016/j.jhep.2009.04.009.
  • OLSSON, Rolf; DANIELSSON, Åke; JÄRNEROT, Gunnar. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology, 1991-05, roč. 100, čís. 5, s. 1319–1323. Dostupné online [cit. 2019-02-05]. ISSN 0016-5085. DOI: 10.1016/0016-5085(91)90784-i.
  • BOONSTRA, Kirsten; WEERSMA, Rinse K.; VAN ERPECUM, Karel J.. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology, 2013-10-17, roč. 58, čís. 6, s. 2045–2055. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.26565.
  • TRIVEDI, Palak J.; HIRSCHFIELD, Gideon M.. Treatment of autoimmune liver disease: current and future therapeutic options. Therapeutic Advances in Chronic Disease, 2013-02-19, roč. 4, čís. 3, s. 119–141. Dostupné online [cit. 2019-02-05]. ISSN 2040-6223. DOI: 10.1177/2040622313478646.

worldcat.org

  • LAZARIDIS, Konstantinos N.; LARUSSO, Nicholas F.. Primary Sclerosing Cholangitis. New England Journal of Medicine, 2016-09-22, roč. 375, čís. 12, s. 1161–1170. Dostupné online [cit. 2019-02-05]. ISSN 0028-4793. DOI: 10.1056/nejmra1506330.
  • FOLSERAAS, Trine; BOBERG, Kirsten Muri. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease, 2016-02, roč. 20, čís. 1, s. 79–98. Dostupné online [cit. 2019-02-05]. ISSN 1089-3261. DOI: 10.1016/j.cld.2015.08.014.
  • KUMMEN, Martin; SCHRUMPF, Erik; BOBERG, Kirsten Muri. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology, 2013-08, roč. 27, čís. 4, s. 531–542. Dostupné online [cit. 2019-02-05]. ISSN 1521-6918. DOI: 10.1016/j.bpg.2013.06.013.
  • CHARATCHAROENWITTHAYA, Phunchai; LINDOR, Keith D.. Primary sclerosing cholangitis: Diagnosis and management. Current Gastroenterology Reports, 2006-02, roč. 8, čís. 1, s. 75–82. Dostupné online [cit. 2019-02-05]. ISSN 1522-8037. DOI: 10.1007/s11894-006-0067-8.
  • SCHAFFNER, Fenton. Gastrointestinal disease: Pathophysiology diagnosis management. 4th ed. Edited by Marvin H. Sleisenger and John S. Fordtran, 2,027 pp. Philadelphia: W. B. Saunders Co., 1989. $155. Hepatology, 1990-10, roč. 12, čís. 4, s. 788–789. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.1840120431.
  • WILLIAMSON, Kate D.; CHAPMAN, Roger W.. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin, 2015-05-16, roč. 114, čís. 1, s. 53–64. Dostupné online [cit. 2019-02-05]. ISSN 0007-1420. DOI: 10.1093/bmb/ldv019.
  • TABIBIAN, James H.; YANG, Ju Dong; BARON, Todd H.. Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. Digestive Diseases and Sciences, 2015-09-21, roč. 61, čís. 1, s. 53–61. Dostupné online [cit. 2019-02-05]. ISSN 0163-2116. DOI: 10.1007/s10620-015-3853-z.
  • TABIBIAN, James H.; ABU DAYYEH, Barham K.; GORES, Gregory J.. A novel, minimally invasive technique for management of peristomal varices. Hepatology, 2015-07-04, roč. 63, čís. 4, s. 1398–1400. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.27925.
  • TABIBIAN, James H; LINDOR, Keith D. Primary sclerosing cholangitis: a review and update on therapeutic developments. Expert Review of Gastroenterology & Hepatology, 2013-02, roč. 7, čís. 2, s. 103–114. Dostupné online [cit. 2019-02-05]. ISSN 1747-4124. DOI: 10.1586/egh.12.80.
  • O’HARA, Steven P.; TABIBIAN, James H.; SPLINTER, Patrick L.. The dynamic biliary epithelia: Molecules, pathways, and disease. Journal of Hepatology, 2013-03, roč. 58, čís. 3, s. 575–582. Dostupné online [cit. 2019-02-05]. ISSN 0168-8278. DOI: 10.1016/j.jhep.2012.10.011.
  • TABIBIAN, James H.; O’HARA, Steven P.; LINDOR, Keith D.. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scandinavian Journal of Gastroenterology, 2014-07-03, roč. 49, čís. 8, s. 901–908. Dostupné online [cit. 2019-02-05]. ISSN 0036-5521. DOI: 10.3109/00365521.2014.913189.
  • TABIBIAN, James H.; VARGHESE, Cyril; O'HARA, Steven P.. Microbiome-immune interactions and liver disease. Clinical Liver Disease, 2015-04, roč. 5, čís. 4, s. 83–85. Dostupné online [cit. 2019-02-05]. ISSN 2046-2484. DOI: 10.1002/cld.453.
  • TABIBIAN, James H.; VARGHESE, Cyril; LARUSSO, Nicholas F.. The enteric microbiome in hepatobiliary health and disease. Liver International, 2015-12-12, roč. 36, čís. 4, s. 480–487. Dostupné online [cit. 2019-02-05]. ISSN 1478-3223. DOI: 10.1111/liv.13009.
  • TABIBIAN, James H.; O'HARA, Steven P.; SPLINTER, Patrick L.. Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis. Hepatology, 2014-04-25, roč. 59, čís. 6, s. 2263–2275. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.26993.
  • TABIBIAN, James H; TRUSSONI, Christy E; O'HARA, Steven P. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis. Laboratory Investigation, 2014-07-21, roč. 94, čís. 10, s. 1126–1133. Dostupné online [cit. 2019-02-05]. ISSN 0023-6837. DOI: 10.1038/labinvest.2014.94.
  • HIRSCHFIELD, Gideon M; KARLSEN, Tom H; LINDOR, Keith D. Primary sclerosing cholangitis. The Lancet, 2013-11, roč. 382, čís. 9904, s. 1587–1599. Dostupné online [cit. 2019-02-05]. ISSN 0140-6736. DOI: 10.1016/s0140-6736(13)60096-3.
  • Robbins basic pathology. Philadelphia, PA : Saunders, 2003. (7th ed.) Dostupné online. ISBN 0721692745.
  • TABIBIAN, James H; MACURA, Slobodan I; O'HARA, Steven P. Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography. Laboratory Investigation, 2013-04-15, roč. 93, čís. 6, s. 733–743. Dostupné online [cit. 2019-02-05]. ISSN 0023-6837. DOI: 10.1038/labinvest.2013.52.
  • LINDOR, Keith D.; KOWDLEY, Kris V.; LUKETIC, Velimir A. C.. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 2009-05-20, roč. 50, čís. 3, s. 808–814. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.23082.
  • EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology, 2009-08, roč. 51, čís. 2, s. 237–267. Dostupné online [cit. 2019-02-05]. ISSN 0168-8278. DOI: 10.1016/j.jhep.2009.04.009.
  • OLSSON, Rolf; DANIELSSON, Åke; JÄRNEROT, Gunnar. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology, 1991-05, roč. 100, čís. 5, s. 1319–1323. Dostupné online [cit. 2019-02-05]. ISSN 0016-5085. DOI: 10.1016/0016-5085(91)90784-i.
  • BOONSTRA, Kirsten; WEERSMA, Rinse K.; VAN ERPECUM, Karel J.. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology, 2013-10-17, roč. 58, čís. 6, s. 2045–2055. Dostupné online [cit. 2019-02-05]. ISSN 0270-9139. DOI: 10.1002/hep.26565.
  • TRIVEDI, Palak J.; HIRSCHFIELD, Gideon M.. Treatment of autoimmune liver disease: current and future therapeutic options. Therapeutic Advances in Chronic Disease, 2013-02-19, roč. 4, čís. 3, s. 119–141. Dostupné online [cit. 2019-02-05]. ISSN 2040-6223. DOI: 10.1177/2040622313478646.